Technical Analysis for NVRO - Nevro Corp.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 4.28 | 1.18% | 0.05 |
NVRO closed down 0.24 percent on Wednesday, November 20, 2024, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Calm After Storm | Range Contraction | 1.18% | |
| NR7 | Range Contraction | 1.18% | |
| NR7-2 | Range Contraction | 1.18% | |
| Narrow Range Bar | Range Contraction | 1.18% | |
| Wide Bands | Range Expansion | 1.18% | |
| Down 3 Days in a Row | Weakness | 1.18% | |
| Oversold Stochastic | Weakness | 1.18% | |
| Calm After Storm | Range Contraction | 0.94% | |
| NR7 | Range Contraction | 0.94% | |
| NR7-2 | Range Contraction | 0.94% |
| Alert | Time |
|---|---|
| Rose Above Previous Day's High | about 2 hours ago |
| Up 1% | about 2 hours ago |
| Down 3% | 1 day ago |
| Fell Below Previous Day's Low | 1 day ago |
| Down 2 % | 1 day ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/11/2024
Nevro Corp., a medical device company, develops and commercializes a neuromodulation platform for the treatment of chronic pain. It provides Senza system, a spinal cord stimulation system that delivers its proprietary HF10 therapy. The company was founded in 2006 and is headquartered in Menlo Park, California.
Sector: Healthcare
Industry: Medical Devices
Keywords: Pain Neuroscience Chronic Pain Pain Management Neuromodulation Neurophysiology Neurotechnology Treatment Of Chronic Pain Spinal Cord Nociception
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Pain Neuroscience Chronic Pain Pain Management Neuromodulation Neurophysiology Neurotechnology Treatment Of Chronic Pain Spinal Cord Nociception
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 22.64 |
| 52 Week Low | 3.95 |
| Average Volume | 559,150 |
| 200-Day Moving Average | 9.26 |
| 50-Day Moving Average | 5.14 |
| 20-Day Moving Average | 4.97 |
| 10-Day Moving Average | 4.66 |
| Average True Range | 0.46 |
| RSI (14) | 38.65 |
| ADX | 10.27 |
| +DI | 27.70 |
| -DI | 28.68 |
| Chandelier Exit (Long, 3 ATRs) | 5.46 |
| Chandelier Exit (Short, 3 ATRs) | 5.34 |
| Upper Bollinger Bands | 5.99 |
| Lower Bollinger Band | 3.94 |
| Percent B (%b) | 0.14 |
| BandWidth | 41.43 |
| MACD Line | -0.25 |
| MACD Signal Line | -0.14 |
| MACD Histogram | -0.1102 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 4.57 | ||||
| Resistance 3 (R3) | 4.54 | 4.41 | 4.51 | ||
| Resistance 2 (R2) | 4.41 | 4.32 | 4.42 | 4.49 | |
| Resistance 1 (R1) | 4.32 | 4.27 | 4.36 | 4.34 | 4.47 |
| Pivot Point | 4.18 | 4.18 | 4.20 | 4.19 | 4.18 |
| Support 1 (S1) | 4.09 | 4.10 | 4.14 | 4.12 | 3.99 |
| Support 2 (S2) | 3.96 | 4.04 | 3.97 | 3.97 | |
| Support 3 (S3) | 3.87 | 3.96 | 3.95 | ||
| Support 4 (S4) | 3.89 |
